ASMB · Assembly Biosciences, Inc. · Proposed Sales

$29.80 -0.66 (-2.17%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$606.75M

20.36M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2023-10-03	William E. Delaney IV	Officer	1,891	$1,607	2023-10-03	Morgan Stanley Smith Barney LLC
2023-10-03	Jason A. Okazaki	Officer, Director	2,363	$2,009	2023-10-03	Morgan Stanley Smith Barney LLC
2023-08-02	William E. Delaney IV	Officer	9,461	$10,293	2023-08-02	Morgan Stanley Smith Barney LLC
2023-08-02	Jason Okazaki	Officer, Director	11,827	$12,867	2023-08-02	Morgan Stanley Smith Barney LLC
2023-05-30	William E. Delaney IV	Officer	4,232	$4,046	2023-05-30	Morgan Stanley Smith Barney LLC
2023-05-23	Jason Okazaki	Officer, Director	6,561	$6,825	2023-05-23	Morgan Stanley Smith Barney LLC
2023-05-23	John G. McHutchison	Director	25,972	$27,019	2023-05-23	Morgan Stanley Smith Barney LLC
2023-05-23	William E. Delaney IV	Officer	6,561	$6,825	2023-05-23	Morgan Stanley Smith Barney LLC

Showing 1–8 of 8 filings

Key facts CIK 1426800 CUSIP 045396207 13F (30d) 3 filings 3 filers Visit website Investor relations